West Pharmaceutical Services, Inc.
WST
$230.11
$6.382.85%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.04% | -15.69% | -28.24% | -17.64% | 33.01% |
| Total Depreciation and Amortization | 13.37% | 12.61% | 14.08% | 12.66% | 15.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -110.69% | -51.81% | -86.79% | -85.71% | 306.84% |
| Change in Net Operating Assets | -12.64% | -100.40% | 155.73% | 26.07% | -76.75% |
| Cash from Operations | -20.49% | -21.73% | -2.48% | -14.41% | 3.60% |
| Capital Expenditure | 3.50% | 15.14% | -32.89% | -10.35% | -14.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 200.00% | -900.00% | 85.07% | -- | -200.00% |
| Cash from Investing | 3.68% | 14.21% | -23.26% | -10.35% | -14.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 85.71% | -22,100.00% | -11,580.00% | 0.00% | -16.67% |
| Issuance of Common Stock | 0.00% | -70.59% | -44.26% | 9.80% | -39.22% |
| Repurchase of Common Stock | 69.17% | -86.48% | -7.34% | -280.45% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.38% | -3.57% | -3.55% | -4.26% | -4.96% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 63.64% | -188.79% | -23.47% | -281.69% | -1,894.74% |
| Foreign Exchange rate Adjustments | -256.55% | 213.27% | -266.67% | -224.29% | -62.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.91% | -56.30% | -72.89% | -3,051.25% | -127.04% |
